| Completed | Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment Iron-deficiency | N/A | 2022-11-15 |
| Completed | A Drug-Drug Interaction Study of Warfarin and PA21 Drug Interaction Potentiation | Phase 1 | 2011-11-01 |
| Completed | A Drug-Drug Interaction Study of Digoxin and PA21 Drug Interaction Potentiation | Phase 1 | 2011-11-01 |
| Completed | A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Ir Iron Deficiency, Chronic Heart Failure | Phase 4 | 2011-10-01 |
| Completed | A Drug-Drug Interaction Study of Omeprazole and PA21 Healthy | Phase 1 | 2011-09-01 |
| Completed | A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Chronic Kidney Disease Requiring Chronic Dialysis | Phase 3 | 2011-09-01 |
| Completed | Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failur Iron Deficiency, Chronic Heart Failure | Phase 3 | 2011-07-01 |
| Completed | A Drug-Drug Interaction Study of Furosemide and PA21 Healthy | Phase 1 | 2011-07-01 |
| Completed | A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients Chronic Kidney Disease Requiring Chronic Dialysis | Phase 3 | 2011-03-01 |
| Completed | A Drug-Drug Interaction Study of Losartan and PA21 Drug Interaction Potentiation | Phase 1 | 2011-03-01 |
| Completed | Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Beari Iron Deficiency | Phase 4 | 2010-06-01 |
| Completed | Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficienc Anaemia | Phase 3 | 2010-05-01 |
| Completed | Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy Iron-Deficiency Anemia | Phase 3 | 2010-05-01 |
| Terminated | Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemother Iron-Deficiency Anemia | Phase 4 | 2010-03-01 |
| Completed | Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chr Iron Deficiency Anaemia, Chronic Kidney Disease | Phase 3 | 2009-12-01 |
| Completed | Maintenance Treatment of Iron Deficiency in IBD Patients Iron Deficiency, Inflammatory Bowel Disease | Phase 3 | 2009-02-01 |
| Terminated | EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure, Iron Deficiency, Iron Deficiency Anemia | Phase 3 | 2008-12-01 |
| Completed | Study of Phosphate Levels in Patients With Chronic Kidney Disease Chronic Kidney Disease | Phase 2 | 2008-12-01 |
| Completed | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR Inflammatory Bowel Disease, Anemia, Iron Deficiency | Phase 3 | 2008-10-01 |
| Completed | Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) Chronic Heart Failure, Iron Deficiency, Iron Deficiency Anemia | Phase 3 | 2007-04-01 |
| Terminated | Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD) Thrombocytosis, Iron-Deficiency Anemia | Phase 2 | 2006-12-01 |
| Completed | Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2003-07-01 |